Huntsville-based Institute will work with AWS to help improve the lives of children with rare diseases and their families
HUNTSVILLE, Ala. (October 6, 2025) — HudsonAlpha Institute for Biotechnology today announced it has been selected as a winner of the 2025 Amazon Web Services (AWS) Imagine Grant: Children’s Health Innovation Award, a grant opportunity designed to accelerate innovation to improve children’s health outcomes with the use of advanced cloud services.
By focusing on children’s health, AWS seeks to bring more focus and attention to a wide variety of causes and care organizations that are dedicated to helping children live longer, healthier lives through the strategic use of cloud technology. The grant will support HudsonAlpha’s efforts to help clinicians and researchers better understand rare diseases that affect children and their families.
HudsonAlpha was named a recipient in the Children’s Health Innovation Award category, which recognizes highly innovative, mission-critical projects accelerating children’s health innovation using advanced cloud services. HudsonAlpha will receive a combination of funding and AWS computing credits, along with implementation support from technical specialists. Proposals were evaluated based on several criteria, including the innovative and unique nature of the project, impact on mission-critical goals, and clearly defined outcomes and milestones.
“This year’s AWS Children’s Health Innovation Award recipients are truly inspiring,” said Allyson Fryhoff, Managing Director, Global Healthcare and Life Sciences at AWS. “These leading pediatric institutions are using AWS technology to transform how we care for children worldwide. From using generative AI for personalized treatment decisions to creating predictive analytics for disease prevention, their projects share a powerful vision: making high-quality care more accessible, predictive, and effective for every child. At AWS, we’re proud to support this collaborative innovation that’s building a future where every child can access the best possible care, informed by data and delivered with precision and compassion.”
HudsonAlpha will use the grant to further develop its medical analysis tool to help healthcare professionals and researchers better understand rare diseases that affect children and their families. The system utilizes cloud technology and artificial intelligence to rapidly analyze patients’ genetic information, enabling a more accurate determination of the cause of a child’s rare disease and the identification of more effective treatment approaches. The tool is updated with the latest medical discoveries, allowing families to obtain answers about their children’s health conditions.
Since the launch of the Imagine Grant program in 2018, AWS has awarded more than $16 million in unrestricted funding, AWS cloud computing credits, and technical expertise to more than 140 nonprofit organizations. Learn more about past recipients and how nonprofits use AWS to advance their missions around the world at the AWS for nonprofits hub.
For more information on the AWS Imagine Grant, visit the Imagine Grant website.
About HudsonAlpha
HudsonAlpha Institute for Biotechnology is a nonprofit organization dedicated to improving the human condition around the globe through discovery, education, and economic development in the genomic sciences. HudsonAlpha’s mission is to develop and apply scientific advances to health, agriculture, education and commercialization. The campus includes nearly 50 biotech companies and consists of 152 acres located within Cummings Research Park, the second-largest research park in the nation. To learn more about HudsonAlpha, visit hudsonalpha.org.
